TRAF2 in osteotropic breast cancer cells enhances skeletal tumour growth and promotes osteolysis
Prabha Peramuhendige(Edinburgh Cancer Research), Aymen I. Idris(University of Aberdeen)
Cited by 39
Related Papers
Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors
|Nature Medicine|2005|349
Combined administration of a small-molecule inhibitor of TRAF6 and Docetaxel reduces breast cancer skeletal metastasis and osteolysis
|Cancer Letters|2020|27
Bidirectional regulation of bone formation by exogenous and osteosarcoma-derived Sema3A
|Scientific Reports|2018|12